SAGE-217

Is There Any Hope Left for Sage Therapeutics?
Motley Fool
Tue, 06/9/20 - 11:02 am
SAGE Therapeutics
SAGE-217
SAGE-324
Sage to run 3 new studies to save once-failed depression drug
Fierce Biotech
Wed, 03/18/20 - 10:14 am
SAGE Therapeutics
SAGE-217
major depressive disorder
clinical trials
Sage rethinks SAGE-217 program after phase 3 failure
Fierce Biotech
Thu, 02/27/20 - 10:32 am
SAGE Therapeutics
clinical trials
depression
SAGE-217
Here's Why Sage Therapeutics Lost 53.3% in December
Motley Fool
Mon, 01/6/20 - 11:28 pm
SAGE Therapeutics
SAGE-217
major depressive disorder
clinical trials
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
Xconomy
Thu, 12/5/19 - 10:11 am
SAGE Therapeutics
clinical trials
SAGE-217
major depressive disorder
Upcoming events – Sage targets depression and Biogen aims for lupus
EP Vantage
Fri, 10/4/19 - 10:03 am
SAGE Therapeutics
SAGE-217
major depressive disorder
Biogen
BIIB059
lupus
Sage Therapeutics Updates Pipeline to Focus on Treatment-Resistant Depression
BioSpace
Thu, 07/25/19 - 07:07 pm
SAGE Therapeutics
treatment-resistant depression
SAGE-217
Here's Why Sage Therapeutics Gained 48.9% in January
Motley Fool
Sun, 02/10/19 - 11:04 pm
SAGE Therapeutics
SAGE-217
postpartum depression
clinical trials
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
Thu, 01/10/19 - 08:48 pm
JPMHC 2019
SAGE Therapeutics
SAGE-217
Mersana
Novavax
Denali Therapeutics
AstraZeneca
Amarin
FDA
government shutdown
Sage shrugs off potential competition in postpartum depression, asserts plan to remain independent
Endpoints
Tue, 01/8/19 - 09:28 am
SAGE Therapeutics
postpartum depression
SAGE-217
Sage Therapeutics pill improves postpartum depression in pivotal clinical trial
Stat
Mon, 01/7/19 - 10:12 am
SAGE Therapeutics
clinical trials
postpartum depression
SAGE-217
On a roll, Sage grabs a $575M deal on limited Asian rights to SAGE-217 — a potential gamechanger in depression
Endpoints
Wed, 06/13/18 - 09:48 pm
SAGE Therapeutics
SAGE-217
Asia
Shionogi
depression
Sage to Expedite Development of SAGE-217 in Major Depressive Disorder and Postpartum Depression
CP Wire
Tue, 06/12/18 - 10:00 am
SAGE Therapeutics
FDA
breakthrough status
SAGE-217
major depressive disorder
postpartum depression
Sage to Expedite Development of SAGE-217 in Major Depressive Disorder and Postpartum Depression
Tue, 06/12/18 - 09:42 am
SAGE Therapeutics
SAGE-217
major depressive disorder
postpartum depression
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Xconomy
Thu, 12/7/17 - 09:18 am
SAGE Therapeutics
major depressive disorder
SAGE-217
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Yahoo/24-7 Wall St
Mon, 02/13/17 - 03:32 pm
SAGE Therapeutics
major depressive disorder
SAGE-217